The IMV Technologies Group announces a change at the head of its company: as of April 1, 2025, Oliver Kohlhaas succeeds Alain de Lambilly as CEO of the IMV Technologies Group. Alain de Lambilly, who has successfully managed the company in recent years, is leaving the Group due to family reasons.
More information
IMV Technologies announces today that Conception Ro-Main Inc. (Ro-Main), a leading developer of technological solutions for pig producers based in Quebec, Canada, will join the Farm Animal business of the IMV Technologies Group.
More information
We are delighted to announce the acquisition of UD-Vet B.V. by IMV Technologies.
More information
We are delighted to announce the acquisition of Medivet Scandinavian AB by IMV Technologies.
More information
A worldwide first in bovine ultrasound imaging is set to boost dairy farm productivity and profitability through improved access to fertility information. Ultrasound reimagined. Bringing fertility into focus for conception rate success.
More information
May 31st 2023, L’Aigle, France- IMV Technologies is delighted to announce the acquisition of Veterinary Solutions, a leading developer of veterinary digital radiography X-Ray (DR X-Ray) systems and veterinary patient archiving and communication system (PACS) software, based in Belgium.
Veterinary Solutions will join the companion animal business of the IMV Technologies Group.
We are pleased to announce the launch of our next-generation printing solution, IRIS Compact, bringing state-of-the-art features and performance.
More information
IMV Group will sponsor the 19th International Congress on Animal Reproduction (ICAR) in Bologna from the 26th to the 30th of June 2022.
More information
January 28, 2022, L’Aigle, France- IMV Technologies announced today the acquisition of VES Custom Optics (VESCO), a leading veterinary endoscopy company based in the United Kingdom.
More information
L’Aigle, April 29, 2021– IMV Technologies, leader in assisted reproduction solutions and veterinary imaging, is pleased to announce that it has joined the group of companies in Montagu Private Equity‘s portfolio.
More information
IMV Technologies has completed the acquisition of Genetirate, a biotechnology company focused on accelerating the sustainability of aquaculture. Genetirate was launched in 2018 around a technology capable of identifying and sorting aquatic animal species (fish, crustaceans, and mollusks) by their metabolic rate. In spring 2019, Genetirate received the North Atlantic Seafood Forum’s Seafood Innovation Award for improving sustainability and production.
More information
Paris, 20 January 2021 – Montagu Private Equity (“Montagu”), a leading European private equity firm, announces today that it has entered exclusive negotiations with Qualium Investissement and management to acquire IMV Technologies.
More information
l’Aigle, France, December 21, 2020.- IMV Technologies has successfully completed the acquisition of Tecnovet, SL, a Spanish company specialized in swine artificial insemination technology and other veterinary products. Tecnovet is recognized worldwide for its Import-vet line of swine insemination products.
More information
IMV Technologies, world leader in assisted reproduction biotechnologies, announces the appointment of Mr. Alain de Lambilly as CEO of the IMV Technologies group, effective Jan. 6, 2020.
More information
IMV Technologies participated in the VI Congreso Iberoamericano de Porcicultura, an international exhibition for pork producers from all Spanish and Portuguese speaking countries in Europe and the Americas, Sept. 18-20, in Panama.
The congress had over 900 participants and featured a two-day technical meeting on topics including health, nutrition, artificial insemination and other pork production topics.
BactiBag, the only bacteriostatic packaging for swine semen, presented at the ICBSP in Australia
More information
